Clinical trials recruiting in Mackay, Australia

Phase breakdown

Conditions recruiting in Mackay, Australia

Recruiting trials in Mackay, Australia

• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
  NCT06119581 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT06588855 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
  NCT06819891 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
  NCT05072314 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female
• Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
  NCT03573089 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
  NCT02823821 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Mackay, Australia?

6 recruiting trials have at least one study site in Mackay, Australia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.